Adapting the Ages and Stages Questionnaire to Identify and Quantify Development Among Children With Evidence of Zika Infection.

Ages and Stages Questionnaire Zika virus child development developmental screening microcephaly neurotropic infection quantitative methods

Journal

Infants and young children
ISSN: 0896-3746
Titre abrégé: Infants Young Child
Pays: United States
ID NLM: 8915767

Informations de publication

Date de publication:
Jun 2020
Historique:
entrez: 2 11 2020
pubmed: 3 11 2020
medline: 3 11 2020
Statut: ppublish

Résumé

This article describes novel methods of applying the Ages and Stages Questionnaire-3rd edition (ASQ-3) to assess and quantify developmental delay among children following the 2015-2016 Zika virus outbreak in Brazil. Many of the children with Zika virus infection were expected to have severe developmental delay. However, administering the ASQ-3 to caregivers of these children according to standard protocol would have screened for the overall presence of delay but not the severity of delay. We adopted an amended protocol for administration of the ASQ-3 to quantify the developmental functioning of children severely affected by Zika virus infection in this investigation. Protocols for administering the ASQ-3 among this population were drafted in consultation with developmental measurement experts and are presented here. Specific developmental estimates are discussed, including developmental age equivalents, developmental quotients, and developmental quotient

Identifiants

pubmed: 33132516
doi: 10.1097/iyc.0000000000000161
pmc: PMC7595748
mid: NIHMS1630490
doi:

Types de publication

Journal Article

Langues

eng

Pagination

95-107

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : CGH CDC HHS
ID : U2G GH001152
Pays : United States

Références

Environ Int. 2018 Jan;110:71-79
pubmed: 29089166
MMWR Morb Mortal Wkly Rep. 2017 Dec 15;66(49):1347-1351
pubmed: 29240727
Hum Mov Sci. 2018 Apr;58:69-79
pubmed: 29353093
Glob Pediatr Health. 2015 Oct 06;2:2333794X15610038
pubmed: 27335984
Early Educ Dev. 2017;28(1):1-20
pubmed: 28785157
PLoS One. 2015 Jul 20;10(7):e0133087
pubmed: 26193474
Pediatrics. 2018 Feb;141(Suppl 2):S154-S160
pubmed: 29437048
Child Care Health Dev. 2010 Jul;36(4):485-90
pubmed: 20030657
Pediatrics. 2008 May;121(5):906-14
pubmed: 18450893
Psychiatr Serv. 2009 Oct;60(10):1323-8
pubmed: 19797371
PLoS One. 2018 Jul 26;13(7):e0201495
pubmed: 30048541
Lancet Child Adolesc Health. 2018 Mar;2(3):205-213
pubmed: 30169255
Biomed Res Int. 2013;2013:629716
pubmed: 24191247
Int J Speech Lang Pathol. 2014 Feb;16(1):30-5
pubmed: 24397842
Pediatrics. 2006 Jul;118(1):405-20
pubmed: 16818591
J Dev Behav Pediatr. 2019 Jun;40(5):344-353
pubmed: 30921104
Child Dev. 2004 Sep-Oct;75(5):1329-39
pubmed: 15369517
Bol Med Hosp Infant Mex. 2017 Jan - Feb;74(1):5-12
pubmed: 29364814
Public Health. 2015 Dec;129(12):1610-7
pubmed: 26318615
Front Psychol. 2017 Apr 20;8:590
pubmed: 28473784
J Pediatr Health Care. 2010 Mar-Apr;24(2):73-80
pubmed: 20189059
Nutr J. 2013 Apr 23;12:50
pubmed: 23617745
BMJ Open. 2018 Jul 16;8(7):e021304
pubmed: 30012787
J Educ Psychol. 2010 Feb 1;102(1):43-53
pubmed: 20411025
Early Hum Dev. 2013 Aug;89(8):561-76
pubmed: 23507472
Environ Health Perspect. 2007 Jan;115(1):128-33
pubmed: 17366832
Pediatr Clin North Am. 2016 Oct;63(5):851-9
pubmed: 27565363
J Paediatr Child Health. 2018 Mar;54(3):289-295
pubmed: 28960646

Auteurs

Jacob E Attell (JE)

Eagle Global Scientific, LLC, Atlanta, Georgia.

Charles Rose (C)

National Center for Birth Defects and Developmental Disability, U.S. Centers for Disease Control and Prevention, Fort Collins, Colorado.

Jeanne Bertolli (J)

Division of Human Development and Disability, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Kim Kotzky (K)

Division of Human Development and Disability, Oak Ridge Institute for Science and Education, Atlanta, Georgia.

Jane Squires (J)

College of Education, Center on Human Development, University of Oregon, Eugene.

Nevin K Krishna (NK)

Division of State and Local Readiness, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Ashley Satterfield-Nash (A)

Division of Human Development and Disability, Oak Ridge Institute for Science and Education, Atlanta, Georgia.

Georgina Peacock (G)

Division of Human Development and Disability, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Isabela Ornelas Pereira (IO)

Transmissible Diseases Department, Ministry of Health of Brazil.

Ana Carolina Faria E Silva Santelli (ACFES)

Overseas Strategy and Management Branch Brazil, Division of Global HIV & Tuberculosis, U.S. Centers for Disease Control and Prevention, Brasilia, Brazil.

Camille Smith (C)

Division of Congenital and Developmental Disorders, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Classifications MeSH